this will be a bad quarter for bsx . going down
to 15 . major reason for pull back is not rotablade
recall but softening stent market and erosion of market
share.In addition market has lost confidence due to
repeated disapiontments and continuous insider trading
The only people who are buying are traders
looking for a 1/16; they and the millions of burnt BSX
investors are going to be taking EOY tax losses now. Those
earnings will have to be pretty good to make this ship
sail...and I am long.
Boston Scientific current price ->
First resistance for Boston Scientific -> $28.38
(50-day moving average)
Second resistance for
Boston Scientific -> $34.45 (200-day moving
Support for Boston Scientific -> $17.93 (52-week
I've done lot of DD on this company, been watching for
quite sometime. According to my estimation, following
are the approximate numbers, (always do you own DD).
What I haven't been able to find (and when I say
haven't been able to, I mean for sure, there are lot of
rumors but nothing concrete) is what's going on with
this company. Until then I'll keep doing DD, hope to
come up with some answeres, and then decide either to
load up or pass.
18 1/2 x 9/16...
but yes, it has bottomed out
so buy, buy, buy. The only way the shorts will make
money is if there is a general market upheaval. Maybe
"all that glitters is not gold" but the market still
has life. But for BSX, today anyway, it will sort of
flicker out towards 4 pm. Good luck to all my devotees.
at 17 and change. With today's rise , it looks
like to have seen the worst already. Need to close
above 19 today and then keep up the rise ... even if
slow... to 20 .. on Tuesday .. as after the results are
announced once its apparent that the earnings are not as
bad as anticipated and with an additional amount of
good / positive news we should be back on the way to
Get in now , as we won't see 17 again...
its all up from here.
Good luck to all BSX longs !
should be the bottom this time.I do not think we
will see 15.Unless the Q'3 results are worse than
indicated. The Q'3 results are due to be released on Tuesday
at 4 pm , but the stock price has already factored
in the expectations of disappointing results -
however, better than indicated earnings or higher gross
sales or higher than expected stent sales or good news
regarding the progress on getting the Rotablator back to
the market - will send the price upwards of 20 , may
be to the 22-26 levels.
You are right ... there
appears to be a lot of support at 18, however expect to
see a temporary dip intra-day to a figure > 16
either today or monday.
Then the tide will turn and
BSX will be on an upward trend , rapidly !